• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Archives of Pharmaceutical Sciences Ain Shams University
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 6 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Hussein, S., Tolba, M., Michel, H., Azab, S. (2022). Insights into the neuroprotective properties of Biochanin-A. Archives of Pharmaceutical Sciences Ain Shams University, 6(2), 181-195. doi: 10.21608/aps.2022.154272.1097
Sarah Hussein; Mai Fathy Tolba; Haidy E Michel; Samar Azab. "Insights into the neuroprotective properties of Biochanin-A". Archives of Pharmaceutical Sciences Ain Shams University, 6, 2, 2022, 181-195. doi: 10.21608/aps.2022.154272.1097
Hussein, S., Tolba, M., Michel, H., Azab, S. (2022). 'Insights into the neuroprotective properties of Biochanin-A', Archives of Pharmaceutical Sciences Ain Shams University, 6(2), pp. 181-195. doi: 10.21608/aps.2022.154272.1097
Hussein, S., Tolba, M., Michel, H., Azab, S. Insights into the neuroprotective properties of Biochanin-A. Archives of Pharmaceutical Sciences Ain Shams University, 2022; 6(2): 181-195. doi: 10.21608/aps.2022.154272.1097

Insights into the neuroprotective properties of Biochanin-A

Article 2, Volume 6, Issue 2, December 2022, Page 181-195  XML PDF (706.74 K)
Document Type: Review Article
DOI: 10.21608/aps.2022.154272.1097
Authors
Sarah Hussein email 1; Mai Fathy Tolba2; Haidy E Michelorcid 2; Samar Azab3
1The Center of Drug Discovery Research and Development, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt
Abstract
Abstract
The global morbidity and mortality caused by neurological disorders are significant. Neurodegenerative disorders are anticipated to rise as the population ages because they typically manifest in mid-to-late life. The World Health Organization predicts that by 2050, two billion individuals would be 60 or older. So an emerging need for neuroprotective agents derived from natural sources with high efficacy and high safety profile. one of these natural agents is biochanin A, an isoflavone belonging to phytoestrogens, mainly found in red clover, soy, and chickpea, commercially available as a tablet, and has a wide range of pharmacological effects, such as antioxidant, anti-inflammatory, anti-apoptotic, antimicrobial, Estrogen-like, glucose and lipid metabolism modulatory, anti-cancer, and neuroprotective effects. Biochanin A was proven to be effective in multiple neurological diseases such as Alzheimer’s and Parkinson’s diseases, multiple sclerosis, stroke, brain injury, depression, anxiety, and glioblastoma. This review concentrates on the possible molecular mechanisms responsible for the neuroprotective effects of biochanin A in various neurological disorders.
Keywords
Biochanin A; neuroprotective; neurological disorder; antioxidant; anti-inflammatory; Alzheimer’s; Parkinson’s diseases; glioblastoma
Statistics
Article View: 195
PDF Download: 149
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.